Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build

Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ActivityDefinition: CMV IgG Antibody CLL

Official URL: https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/CMVAntibodyIgGCLL Version: Langversion 2.01
Active as of 2025-01-16 Responsible: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll Computable Name: CMVAntibodyIgGCLL

CMV IgG Antikörper Bestimmung

Generated Narrative: ActivityDefinition CMVAntibodyIgGCLL

knowledgeCapability: computable

knowledgeRepresentationLevel: structured

url: ActivityDefinition CMV IgG Antibody CLL

version: Langversion 2.01

name: CMVAntibodyIgGCLL

title: CMV IgG Antibody CLL

status: Active

experimental: false

subject: Patient

date: 2025-01-16 09:02:23+0000

publisher: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll

description:

CMV IgG Antikörper Bestimmung

kind: ServiceRequest

code: CMV (cytomegalovirus) IgG antibody in serum qualitative result

timing: Count 1 times, Once